Genetic Mutation Analysis Global Market Report 2025

Description

Genetic mutation analysis involves the study and assessment of changes in an organism's DNA sequence that alter its genetic code. It is primarily concerned with identifying and characterizing variations such as base substitutions, insertions, deletions, or structural rearrangements within specific genes or genomic regions. The purpose of this process is to evaluate the nature and potential impact of these changes, providing valuable insights into the patterns, diversity, and consequences of genetic alterations.

The core components of genetic mutation analysis include hardware, software, and services. Hardware refers to the laboratory instruments used to extract, amplify, and examine genetic material for mutation detection. A range of technologies is applied in this process, including next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray, Sanger sequencing, and clustered regularly interspaced short palindromic repeats (CRISPR). Genetic mutation analysis is utilized across multiple applications, such as oncology, cardiovascular diseases, neurological disorders, infectious diseases, genetic disorders, and pharmacogenomics. Its primary end users include hospitals and clinics, research institutions, pharmaceutical and biotechnology companies, and diagnostic laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The genetic mutation analysis market research report is one of a series of new reports from The Business Research Company that provides genetic mutation analysis market statistics, including the genetic mutation analysis industry global market size, regional shares, competitors with the genetic mutation analysis market share, detailed genetic mutation analysis market segments, market trends, and opportunities, and any further data you may need to thrive in the genetic mutation analysis industry. This genetic mutation analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The genetic mutation analysis market size has grown rapidly in recent years. It will grow from $5.94 billion in 2024 to $6.65 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth during the historic period can be attributed to the rising prevalence of genetic and inherited disorders, increasing awareness of the benefits of personalized medicine, advancements in sequencing technologies, wider adoption of liquid biopsy techniques, and greater integration of AI and big data analytics.

The genetic mutation analysis market size is expected to see rapid growth in the next few years. It will grow to $10.30 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period is expected to be driven by increasing government initiatives and funding for genomics research, rising demand for early disease detection and preventive testing, expanded access to direct-to-consumer (DTC) genetic testing, growing demand in oncology and infectious disease monitoring, and heightened focus on reproductive and prenatal genomic applications. Key trends anticipated during this period include advancements in sequencing technologies, integration of AI and bioinformatics tools, innovations in rare mutation detection, progress in lab-on-a-chip and microfluidics technologies, and the adoption of accelerated computing.

The increasing prevalence of genetic disorders is expected to drive the growth of the genetic mutation analysis market in the coming years. Genetic disorders result from abnormalities or mutations in an individual's DNA, which may be inherited or arise spontaneously. One contributing factor to the rising prevalence of these disorders is advanced parental age, which increases the likelihood of genetic mutations during reproduction. Genetic mutation analysis identifies changes in genes that may cause or indicate the presence of genetic disorders, enabling early diagnosis, targeted therapies, and informed reproductive or lifestyle decisions. For example, in October 2024, the Cystic Fibrosis Trust, a UK-based charity supporting people with cystic fibrosis, reported that registered patients increased from 11,148 in 2022 to 11,318 in 2023, reflecting a 1.5% year-over-year rise. This growing prevalence of genetic disorders is thus driving demand for genetic mutation analysis services.

Companies in the genetic mutation analysis market are developing innovative solutions, such as tissue-based next-generation sequencing (NGS) tests, to improve precision in detecting actionable genetic alterations and guide personalized treatments. Tissue-based NGS tests analyze DNA or RNA from tissue samples to identify genetic mutations, alterations, or biomarkers linked to diseases like cancer. For instance, in June 2024, Guardant Health Inc., a US-based oncology company, launched the Guardant360 TissueNext test, which expanded its tumor tissue gene panel to 498 genes. These biomarkers help oncologists determine the most effective targeted therapies for patients with advanced cancer. Along with panel expansion, Guardant improved the test's workflow to deliver faster results. The Guardant360 TissueNext test will be covered as a standalone service for Medicare fee-for-service patients with advanced solid tumors, based on coverage provided by Palmetto GBA under the Molecular Diagnostics Services (MolDX) program.

In June 2023, Dotmatics Ltd., a US-based scientific informatics software company, acquired SoftGenetics LLC for an undisclosed amount. This acquisition aims to enhance Dotmatics' genomics and bioinformatics capabilities by integrating SoftGenetics' advanced genetic analysis tools. The move strengthens Dotmatics' life sciences R&D platform and expands its presence in precision medicine and genetic research. SoftGenetics LLC, headquartered in the US, specializes in bioinformatics software for mutation detection, sequencing, and forensic applications.

Major players in the genetic mutation analysis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies Plc, Genomic Health Inc., Color Genomics Inc., Blueprint Medicines Corporation, GENEWIZ Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Personalis Inc., LGC Biosearch Technologies LLC, and BGI Genomics Co. Ltd.

North America was the largest region in the genetic mutation analysis market in 2024. The regions covered in genetic mutation analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the genetic mutation analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genetic mutation analysis market consists of revenues earned by entities by providing services such as mutation validation, biomarker discovery, genome annotation, structural variation analysis, and epigenetic profiling. The market value includes the value of related goods sold by the service provider or included within the service offering. The genetic mutation analysis market also includes sales of DNA extraction tools, mutation detection assays, sequencing panels, and genomic reference materials. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genetic Mutation Analysis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genetic mutation analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genetic mutation analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genetic mutation analysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Component: Hardware; Software; Services
2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarray; Sanger Sequencing; Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
3) By Application: Oncology; Cardiovascular Diseases; Neurological Disorders; Infectious Diseases; Genetic Disorders; Pharmacogenomics
4) By End User: Hospitals And Clinics; Research Institutes; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories
Subsegment:
1) By Hardware: Sequencers; Polymerase Chain Reaction (PCR) Machines; Microarray Instruments; Electrophoresis Systems; Imaging Systems
2) By Software: Data Analysis Software; Sequence Alignment Tools; Variant Calling Software; Genome Annotation Software; Visualization Tools
3) By Services: Genetic Testing Services; Data Interpretation Services; Bioinformatics Services; Sample Preparation Services; Clinical Reporting Services
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Illumina Inc.; Revvity Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Natera Inc.; Myriad Genetics Inc.; GenScript Biotech Corporation; Takara Bio Inc.; 10x Genomics Inc.; Oxford Nanopore Technologies Plc; Genomic Health Inc.; Color Genomics Inc.; Blueprint Medicines Corporation; GENEWIZ Inc.; Pacific Biosciences of California Inc.; Standard BioTools Inc.; Personalis Inc.; LGC Biosearch Technologies LLC; BGI Genomics Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r37768

1. Executive Summary

2. Genetic Mutation Analysis Market Characteristics

3. Genetic Mutation Analysis Market Trends And Strategies

4. Genetic Mutation Analysis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Genetic Mutation Analysis Growth Analysis And Strategic Analysis Framework

5.1. Global Genetic Mutation Analysis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Genetic Mutation Analysis Market Growth Rate Analysis
5.4. Global Genetic Mutation Analysis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Genetic Mutation Analysis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Genetic Mutation Analysis Total Addressable Market (TAM)

6. Genetic Mutation Analysis Market Segmentation

6.1. Global Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hardware
Software
Services
6.2. Global Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Microarray
Sanger Sequencing
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
6.3. Global Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Cardiovascular Diseases
Neurological Disorders
Infectious Diseases
Genetic Disorders
Pharmacogenomics
6.4. Global Genetic Mutation Analysis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Research Institutes
Pharmaceutical And Biotechnology Companies
Diagnostic Laboratories
6.5. Global Genetic Mutation Analysis Market, Sub-Segmentation Of Hardware By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sequencers
Polymerase Chain Reaction (PCR) Machines
Microarray Instruments
Electrophoresis Systems
Imaging Systems
6.6. Global Genetic Mutation Analysis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Data Analysis Software
Sequence Alignment Tools
Variant Calling Software
Genome Annotation Software
Visualization Tools
6.7. Global Genetic Mutation Analysis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Testing Services
Data Interpretation Services
Bioinformatics Services
Sample Preparation Services
Clinical Reporting Services

7. Genetic Mutation Analysis Market Regional And Country Analysis

7.1. Global Genetic Mutation Analysis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Genetic Mutation Analysis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genetic Mutation Analysis Market

8.1. Asia-Pacific Genetic Mutation Analysis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genetic Mutation Analysis Market

9.1. China Genetic Mutation Analysis Market Overview
9.2. China Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genetic Mutation Analysis Market

10.1. India Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genetic Mutation Analysis Market

11.1. Japan Genetic Mutation Analysis Market Overview
11.2. Japan Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genetic Mutation Analysis Market

12.1. Australia Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genetic Mutation Analysis Market

13.1. Indonesia Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genetic Mutation Analysis Market

14.1. South Korea Genetic Mutation Analysis Market Overview
14.2. South Korea Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genetic Mutation Analysis Market

15.1. Western Europe Genetic Mutation Analysis Market Overview
15.2. Western Europe Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genetic Mutation Analysis Market

16.1. UK Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genetic Mutation Analysis Market

17.1. Germany Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genetic Mutation Analysis Market

18.1. France Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genetic Mutation Analysis Market

19.1. Italy Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genetic Mutation Analysis Market

20.1. Spain Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genetic Mutation Analysis Market

21.1. Eastern Europe Genetic Mutation Analysis Market Overview
21.2. Eastern Europe Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genetic Mutation Analysis Market

22.1. Russia Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genetic Mutation Analysis Market

23.1. North America Genetic Mutation Analysis Market Overview
23.2. North America Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genetic Mutation Analysis Market

24.1. USA Genetic Mutation Analysis Market Overview
24.2. USA Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genetic Mutation Analysis Market

25.1. Canada Genetic Mutation Analysis Market Overview
25.2. Canada Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genetic Mutation Analysis Market

26.1. South America Genetic Mutation Analysis Market Overview
26.2. South America Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genetic Mutation Analysis Market

27.1. Brazil Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genetic Mutation Analysis Market

28.1. Middle East Genetic Mutation Analysis Market Overview
28.2. Middle East Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genetic Mutation Analysis Market

29.1. Africa Genetic Mutation Analysis Market Overview
29.2. Africa Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genetic Mutation Analysis Market Competitive Landscape And Company Profiles

30.1. Genetic Mutation Analysis Market Competitive Landscape
30.2. Genetic Mutation Analysis Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Revvity Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Genetic Mutation Analysis Market Other Major And Innovative Companies

31.1. Bio-Rad Laboratories Inc.
31.2. QIAGEN N.V.
31.3. Natera Inc.
31.4. Myriad Genetics Inc.
31.5. GenScript Biotech Corporation
31.6. Takara Bio Inc.
31.7. 10x Genomics Inc.
31.8. Oxford Nanopore Technologies Plc
31.9. Genomic Health Inc.
31.10. Color Genomics Inc.
31.11. Blueprint Medicines Corporation
31.12. GENEWIZ Inc.
31.13. Pacific Biosciences of California Inc.
31.14. Standard BioTools Inc.
31.15. Personalis Inc.

32. Global Genetic Mutation Analysis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genetic Mutation Analysis Market

34. Recent Developments In The Genetic Mutation Analysis Market

35. Genetic Mutation Analysis Market High Potential Countries, Segments and Strategies

35.1 Genetic Mutation Analysis Market In 2029 - Countries Offering Most New Opportunities
35.2 Genetic Mutation Analysis Market In 2029 - Segments Offering Most New Opportunities
35.3 Genetic Mutation Analysis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer